Deutsche Bank
ODTX icon

Deutsche Bank’s Odyssey Therapeutics ODTX Stock Holding History

Deutsche Bank’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$313K Buy
+14,106
New +$300K ﹤0.01% 2862

Other funds holding ODTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Deutsche Bank's ODTX Position: Q3 2026 in Review

Deutsche Bank opened a new position in Odyssey Therapeutics (ODTX) in Q3 2026: 14,106 shares worth $313K. The stake represents ﹤0.01% of the portfolio and ranks #2862 among its holdings.

25 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.

  • Deutsche Bank held 14,106 shares of Odyssey Therapeutics worth $313K as of Q3 2026.
  • Odyssey Therapeutics was a new Deutsche Bank position in Q3 2026.
  • Odyssey Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2862 holding.
  • 25 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.